Lamb Weston Holdings Inc
For the period ended Feb 23, 2025. Filed Apr 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 23, 2025 · Filed Apr 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Notes to Consolidated Financial Statements (Unaudited)
Condensed Notes to Consolidated Financial Statements
(Unaudited)
- NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Lamb Weston Holdings, Inc. (“we,” “us,” “our,” the “Company,” or “Lamb Weston”) is a leading global producer, distributor, and marketer of value-added frozen potato products and is headquartered in Eagle, Idaho. We havetwo reportable segments: North America and International. See Note 13, Segments, for additional information on our reportable segments.
Basis of Presentation
The accompanying unaudited Consolidated Financial Statements present the financial results of Lamb Weston and its consolidated subsidiaries for the thirteen and thirty-nine weeks ended February 23, 2025 and February 25, 2024, and have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America (“U.S.”).
These consolidated financial statements are unaudited and include all adjustments that we consider necessary for a fair presentation of such financial statements and consist only of normal recurring adjustments. The preparation of financial statements involves the use of estimates and accruals. The actual results that we experience may differ materially from those estimates. Results for interim periods should not be considered indicative of results for our full fiscal year, which ends the last Sunday in May.
These financial statements and related condensed notes should be read together with the consolidated financial statements and notes in our Annual Report on Form 10-K for the fiscal year ended May 26, 2024 (the “Form 10-K”), where we include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our estimates. We filed the Form 10-K with the Securities and Exchange Commission (the “SEC”) on July 24, 2024.
Certain amounts from prior period consolidated financial statements have been reclassified to conform with current period presentation. These reclassifications had no financial impact on previously reported net income, cash flows, or stockholders' equity.
Accounting Pronouncements Not Yet Adopted
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. ASU 2023-07 is effective for our Annual Report on Form 10-K for the fiscal year ending May 25, 2025, and subsequent interim periods, with early adoption permitted. We are evaluating the impact of adopting this ASU on our reportable segment disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to enhance transparency and decision usefulness of income tax disclosures, particularly around rate reconciliations and income taxes paid information. ASU 2023-09 is effective for our Annual Report on Form 10-K for the fiscal year ending May 31, 2026, on a prospective basis, with early adoption permitted. We are evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), which requires disaggregated disclosure of income statement expenses in public business entities. ASU 2024-03 is effective for our Annual Report on Form 10-K for the fiscal year ending May 28, 2028, and for our Quarterly Reports beginning fiscal year 2029, on a prospective basis, with early adoption permitted. We are evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
There were no other accounting pronouncements recently issued that had or are expected to have a material impact on our consolidated financial statements.
- EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per common share for the periods presented:
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||
|---|---|---|---|---|
| (in millions, except per share amounts) | February 23,2025 | February 25,2024 | February 23,2025 | February 25,2024 |
| Numerator: | ||||
| Net income | $146.0 | $146.1 | $237.3 | $595.8 |
| Denominator: | ||||
| Basic weighted average common shares outstanding | 141.9 | 144.5 | 142.8 | 145.0 |
| Add: Dilutive effect of employee incentive plans (a) | 0.5 | 0.8 | 0.4 | 0.8 |
| Diluted weighted average common shares outstanding | 142.4 | 145.3 | 143.2 | 145.8 |
| Earnings per share: | ||||
| Basic | $1.03 | $1.01 | $1.66 | $4.11 |
| Diluted | $1.03 | $1.01 | $1.66 | $4.09 |
(a)Potential dilutive shares of common stock under employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options and the assumed vesting of outstanding restricted stock units and performance awards. As of February 23, 2025,0.6 million shares of stock-based awards were excluded from the computation of diluted earnings per share because they would be antidilutive. As of February 25, 2024, an insignificant number of stock-based awards were excluded from the computation of diluted earnings per share because they would be antidilutive.
- INCOME TAXES
Income tax expense for the periods presented were as follows:
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||
|---|---|---|---|---|
| (in millions) | February 23,2025 | February 25,2024 | February 23,2025 | February 25,2024 |
| Income before income tax expense and equity method earnings | $201.4 | $188.2 | $343.5 | $757.3 |
| Equity method investment earnings | 2.1 | 1.0 | 15.5 | 17.8 |
| Income tax expense | 57.5 | 43.1 | 121.7 | 179.3 |
| Effective tax rate (a) | 28.3% | 22.8% | 33.9% | 23.1% |
(a)The effective income tax rate is calculated as the ratio of income tax expense to pre-tax income, inclusive of equity method investment earnings. The effective tax rate varies from the U.S. statutory tax rate of 21% principally due to the impact of U.S. state taxes, foreign taxes and currency, permanent differences, and discrete items.
During the thirteen and thirty-nine weeks ended February 23, 2025, we recorded a $2.6 million and $38.1 million tax benefit, respectively, related to charges in connection with our previously announced restructuring plan (the “Restructuring Plan”) and for the thirty-nine weeks ended February 23, 2025 a discrete tax expense of $18.2 million, primarily related to the establishment of a non-cash full valuation allowance against certain international deferred tax assets. See Note 4, Restructuring Plan, of these Condensed Notes to Consolidated Financial Statements for more information about the Restructuring Plan.
Income Taxes Paid
Income taxes paid, net of refunds, were $123.6 million and $140.4 million during the thirty-nine weeks ended February 23, 2025 and February 25, 2024, respectively.
- RESTRUCTURING PLAN
On October 1, 2024, we announced the Restructuring Plan, which is designed to drive operational and cost efficiencies and improve cash flows. The Restructuring Plan includes the permanent closure of our manufacturing facility in Connell, Washington, the temporary curtailment of certain production lines and schedules across our manufacturing network in North America, and reductions in employee headcount, other operating expenses, and capital expenditures.
In connection with the Restructuring Plan, we expect to recognize total pre-tax charges of $190 million to $210 million. We expect actions in connection with the Restructuring Plan will be substantially complete by the end of the fourth quarter of fiscal 2025 or early fiscal 2026, and the majority of the remaining charges will relate to facility closure and employee-related costs. Any changes to these estimates or timing will be reflected in our results of operations in future periods.
For the thirteen and thirty-nine weeks ended February 23, 2025, we recorded $10.3 million and $169.4 million of pre-tax charges, of the total charges, $120.2 million were cash and $49.2 million were non-cash.
| (in millions) | Thirteen Weeks Ended February 23, 2025 | Thirty-Nine Weeks Ended February 23, 2025 |
|---|---|---|
| Restructuring Plan expenses related to (a): | ||
| Accelerated depreciation, retirement of assets, and other plant charges (b) | $7.2 | $53.0 |
| Potato contract terminations (c) | (3.2) | 61.5 |
| Inventory write-off (c) | 3.9 | 23.7 |
| Employee-related costs (d) | 0.7 | 16.9 |
| Other restructuring charges | 1.7 | 14.3 |
| $10.3 | $169.4 | |
(a)These charges were included as“unallocated corporate costs” before being reconciled in the Segment Adjusted EBITDA to Net income table in Note 13, Segments, of these Condensed Notes to the Consolidated Financial Statements.
(b)Includes charges related to accelerating depreciation of the manufacturing facility permanently closed under the Restructuring Plan, other asset retirements, and plant charges.
(c)Includes the cost of contracted raw potatoes that will not be used due to curtailed production and the write-off of inventories, including spare parts, related to the production curtailment under the Restructuring Plan.
(d)Includes employee severance and other one-time termination benefits related to the reduction in headcount under the Restructuring Plan.
The following amounts related to the Restructuring Plan are included in the Company’s Consolidated Statements of Earnings:
| (in millions) | Thirteen Weeks Ended February 23, 2025 | Thirty-Nine Weeks Ended February 23, 2025 |
|---|---|---|
| Restructuring Plan expenses included in: | ||
| Cost of sales | $0.7 | $76.2 |
| Restructuring expense | 9.6 | 84.2 |
| Equity method investment earnings | — | 9.0 |
| $10.3 | $169.4 | |
During the thirty-nine weeks ended February 23, 2025, we paid $71.3 million in Restructuring Plan expenses; accruals remaining under the Restructuring Plan of $48.9 million are recorded as current liabilities within “Accounts payable” and “Accrued liabilities” in the accompanying Consolidated Balance Sheet at February 23, 2025.
- INVENTORIES
Inventories are valued at the lower of cost (determined using the first-in, first-out method) or net realizable value and include all costs directly associated with manufacturing products: materials, labor, and manufacturing overhead. The components of inventories were as follows:
| (in millions) | February 23,2025 | May 26,2024 |
|---|---|---|
| Raw materials and packaging | $259.0 | $178.7 |
| Finished goods | 887.1 | 867.9 |
| Supplies and other | 103.2 | 92.0 |
| Inventories | $1,249.3 | $1,138.6 |
- PROPERTY, PLANT AND EQUIPMENT
The components of property, plant and equipment were as follows:
| (in millions) | February 23,2025 | May 26,2024 |
|---|---|---|
| Land and land improvements | $188.1 | $186.2 |
| Buildings, machinery and equipment | 4,978.0 | 4,708.8 |
| Furniture, fixtures, office equipment and other | 154.3 | 127.7 |
| Construction in progress | 531.0 | 688.2 |
| Property, plant and equipment, at cost | 5,851.4 | 5,710.9 |
| Less accumulated depreciation | (2,266.2) | (2,128.1) |
| Property, plant and equipment, net | $3,585.2 | $3,582.8 |
At February 23, 2025 and May 26, 2024, purchases of property, plant and equipment included in accounts payable were $107.7 million and $292.0 million, respectively.
Below is a breakdown of depreciation and amortization between cost of sales (“COS”) and selling, general and administrative expenses (“SG&A”) for the thirteen and thirty-nine weeks ended February 23, 2025 and February 25, 2024.
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||
|---|---|---|---|---|
| (in millions) | February 23,2025 | February 25,2024 | February 23,2025 | February 25,2024 |
| Depreciation - COS | $83.9 | $67.7 | $242.0 | $194.4 |
| Depreciation - SG&A | 4.1 | 3.0 | 11.1 | 8.7 |
| Depreciation - Restructuring expense (a) | 4.5 | — | 33.4 | — |
| $92.5 | $70.7 | $286.5 | $203.1 | |
| Amortization - SG&A | $8.5 | $7.1 | $23.2 | $12.4 |
(a)See Note 4, Restructuring Plan, of these Condensed Notes to Consolidated Financial Statements for additional information.
Interest capitalized within construction in progress for the thirteen weeks ended February 23, 2025 and February 25, 2024, was $4.2 million and $13.8 million, respectively; and $19.1 million and $37.3 million for the thirty-nine weeks ended February 23, 2025 and February 25, 2024, respectively.
- GOODWILL AND OTHER IDENTIFIABLE INTANGIBLE ASSETS
The following table presents changes in goodwill balances, by segment, for the thirty-nine weeks ended February 23, 2025:
| (in millions) | North America | International | Total |
|---|---|---|---|
| Balance at May 26, 2024 | $728.8 | $331.1 | $1,059.9 |
| Foreign currency translation adjustment | (22.6) | (10.3) | (32.9) |
| Balance at February 23, 2025 | $706.2 | $320.8 | $1,027.0 |
Other identifiable intangible assets were as follows:
| February 23, 2025 | May 26, 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| (in millions, except useful lives) | Weighted Average Useful Life (in years) | Gross Carrying Amount | Accumulated Amortization | IntangibleAssets, Net | Weighted Average Useful Life (in years) | Gross Carrying Amount | Accumulated Amortization | IntangibleAssets, Net |
| Non-amortizing intangible assets (a) | n/a | $18.0 | $— | $18.0 | n/a | $18.0 | $— | $18.0 |
| Amortizing intangible assets (b) | 14 | 123.1 | (41.7) | 81.4 | 13 | 123.6 | (36.7) | 86.9 |
| $141.1 | $(41.7) | $99.4 | $141.6 | $(36.7) | $104.9 | |||
(a)Non-amortizing intangible assets represent brands and trademarks.
(b)Amortizing intangible assets are principally composed of licensing agreements, brands, and customer relationships. Foreign intangible assets are affected by foreign currency translation.
- OTHER ASSETS
The components of other assets were as follows:
| (in millions) | February 23,2025 | May 26,2024 |
|---|---|---|
| Capitalized software costs | $212.2 | $227.9 |
| Property, plant and equipment deposits | 74.4 | 52.6 |
| Equity method investments | 49.2 | 59.2 |
| Other | 66.3 | 56.7 |
| Other assets | $402.1 | $396.4 |
- ACCRUED LIABILITIES
The components of accrued liabilities were as follows:
| (in millions) | February 23,2025 | May 26,2024 |
|---|---|---|
| Compensation and benefits | $108.0 | $72.8 |
| Accrued trade promotions | 68.8 | 90.0 |
| Dividends payable to shareholders | 52.2 | 51.7 |
| Plant utilities and accruals | 36.6 | 23.9 |
| Taxes payable | 35.4 | 24.8 |
| Accrued interest | 26.4 | 31.7 |
| Current portion of operating lease obligations | 23.7 | 29.3 |
| Derivative liabilities and payables | 13.2 | 24.6 |
| Other | 27.6 | 58.8 |
| Accrued liabilities | $391.9 | $407.6 |
- DEBT AND FINANCING OBLIGATIONS
The components of our debt, including financing obligations, were as follows:
| (in millions) · February 23, 2025 · May 26, 2024 | |||||
|---|---|---|---|---|---|
| Amount · Interest Rate · Amount · Interest Rate | |||||
| Short-term borrowings: | |||||
| Revolving credit facility | $447.5 | 6.140% | $291.3 | 6.580% | |
| Other credit facilities (a) | 37.7 | 35.0 | |||
| 485.2 | 326.3 | ||||
| Long-term debt: | |||||
| Term A-1 loan facility, due June 2026 (b) | — | — | 228.8 | 7.240 | |
| Term A-3 loan facility, due January 2030 (b) | 410.6 | 7.060 | 427.5 | 7.390 | |
| Term A-4 loan facility, due May 2029 (b) | 316.9 | 6.610 | 325.0 | 6.540 | |
| Term A-5 loan facility, due September 2031 (b) | 500.0 | 5.650 | — | — | |
| RMB loan facility, due February 2027 | 147.1 | 4.090 | 142.2 | 4.450 | |
| RMB loan facility, due September 2029 | 19.5 | 4.000 | — | — | |
| Euro term loan facility, due May 2029 | 209.2 | 4.740 | 216.9 | 5.080 | |
| 4.875% senior notes, due May 2028 | 500.0 | 4.875 | 500.0 | 4.875 | |
| 4.125% senior notes, due January 2030 | 970.0 | 4.125 | 970.0 | 4.125 | |
| 4.375% senior notes, due January 2032 | 700.0 | 4.375 | 700.0 | 4.375 | |
| 3,773.3 | 3,510.4 | ||||
| Financing obligations: | |||||
| Lease financing obligations due on various dates through 2040 | 4.3 | 5.7 | |||
| Total debt and financing obligations | 4,262.8 | 3,842.4 | |||
| Debt issuance costs (c) | (17.7) | (19.0) | |||
| Short-term borrowings | (485.2) | (326.3) | |||
| Current portion of long-term debt and financing obligations | (79.3) | (56.4) | |||
| Long-term debt and financing obligations, excluding current portion | $3,680.6 | $3,440.7 | |||
(a)Other credit facilities consist of short-term facilities at our subsidiaries used for working capital purposes. Borrowings under these facilities bear interest at various rates.
(b)Theinterest rates applicable to the Term A-1, A-3, A-4, and A-5 loans do not include anticipated patronage dividends. We have received and expect to continue receiving patronage dividends under these term loan facilities.
(c)Excludes debt issuance costs of $4.1 million and $4.9 million as of February 23, 2025 and May 26, 2024, respectively, related to our Revolving credit facility, which are recorded in “Other assets” on our Consolidated Balance Sheets.
As of February 23, 2025, we had $1,052.5 million of available liquidity under our committed revolving credit facility.
For the thirty-nine weeks ended February 23, 2025 and February 25, 2024, we paid $167.2 million and $151.3 million of interest on debt, respectively.
For more information about our debt and financing obligations, interest rates, and debt covenants, see Note 6, Debt and Financing Obligations, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K, and Note 9, Debt and Financing Obligations, in “Part I, Item 1. Financial Statements (Unaudited)” of our Quarterly Report on Form 10-Q for the quarter ended August 25, 2024 filed with the SEC on October 2, 2024.
- FAIR VALUE MEASUREMENTS
The fair values of cash equivalents, receivables, accounts payable, and short-term debt approximate their carrying amounts due to their short duration.
The following table presents our financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall:
| (in millions) | Level 1 | Level 2 | Level 3 | Fair Valueof Assets(Liabilities) |
|---|---|---|---|---|
| Derivative assets (a) | $— | $0.8 | $— | $0.8 |
| Derivative liabilities (a) | — | (9.3) | — | (9.3) |
| Deferred compensation liabilities (b) | — | (27.6) | — | (27.6) |
| Fair value, net | $— | $(36.1) | $— | $(36.1) |
| (in millions) | Level 1 | Level 2 | Level 3 | Fair Valueof Assets(Liabilities) |
|---|---|---|---|---|
| Derivative assets (a) | $— | $1.4 | $— | $1.4 |
| Derivative liabilities (a) | — | (21.7) | — | (21.7) |
| Deferred compensation liabilities (b) | — | (27.6) | — | (27.6) |
| Fair value, net | $— | $(47.9) | $— | $(47.9) |
(a)Derivative assets and liabilities included in Level 2 primarily represent commodity swaps, option contracts, interest rate swap and currency contracts. The fair value of these derivatives were determined using valuation models that use market observable inputs including both forward and spot prices. Derivative assets are presented within “Prepaid expenses and other current assets” on our Consolidated Balance Sheets and derivative liabilities are presented within “Accrued liabilities” on our Consolidated Balance Sheets.
(b)The fair values of our Level 2 deferred compensation liabilities were valued using third-party valuations, which are based on the net asset values of mutual funds in our retirement plans. While the underlying assets are actively traded on an exchange, the funds are not. Deferred compensation liabilities are primarily presented within “Other noncurrent liabilities” on our Consolidated Balance Sheets.
As of February 23, 2025, we had $2,997.9 million of fixed-rate and $1,260.6 million of variable-rate debt outstanding. Based on current market rates, the fair value of our fixed-rate debt was estimated to be $2,855 million as of February 23, 2025. Any differences between the book value and fair value are due to the difference between the period-end market interest rate and the stated rate of our fixed-rate debt. The fair value of our variable-rate term debt approximates the carrying amount and approximates current market prices.
- STOCKHOLDERS’ EQUITY
Share Repurchase Program
On December 19, 2024, we announced that our Board of Directors (the “Board”) increased our share repurchase authorization $250 million to an aggregate amount of $750 million. The program has no expiration date. During the thirteen weeks ended February 23, 2025, we repurchased 1,559,369 shares of our common stock for an aggregate purchase price of $100.0 million, or a weighted-average price of $64.13 per share. During the thirty-nine weeks ended February 23, 2025, we repurchased 2,972,221 shares of our common stock for an aggregate purchase price of $182.0 million, or a weighted-average price of $61.23 per share. As of February 23, 2025, approximately $458 million remained authorized for repurchase under our share repurchase program.
Dividends
During the thirty-nine weeks ended February 23, 2025, we paid $154.7 million of cash dividends to our common stockholders. In addition, on February 28, 2025, we paid $52.2 million of cash dividends to common stockholders of record as of the close of business on January 31, 2025. On March 20, 2025, the Board declared a cash dividend of $0.37 per share of our common stock. This dividend will be paid on May 30, 2025, to common stockholders of record as of the close of business on May 2, 2025.
Accumulated Other Comprehensive Income (Loss)
Changes in accumulated other comprehensive income, net of taxes, as of February 23, 2025 were as follows:
| (in millions) | ForeignCurrency Translation Gain (Loss) | Pension and Post-RetirementBenefits | Other | AccumulatedOtherComprehensiveIncome (Loss) |
|---|---|---|---|---|
| Balance as of May 26, 2024 | $(8.2) | $(5.3) | $0.6 | $(12.9) |
| Other comprehensive income before reclassifications, net of tax | (61.0) | (0.2) | (0.3) | (61.5) |
| Net current-period other comprehensive income | (61.0) | (0.2) | (0.3) | (61.5) |
| Balance as of February 23, 2025 | $(69.2) | $(5.5) | $0.3 | $(74.4) |
- SEGMENTS
We havetwo operating segments, each of which is a reportable segment: North America and International. Our chief operating decision maker receives periodic management reports under this structure, which informs operating decisions, performance assessment, and resource allocation decisions at the segment level. These reportable segments are each managed by a general manager and supported by a cross functional team assigned to support the segment.
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||
|---|---|---|---|---|
| (in millions) | February 23,2025 | February 25, 2024 (e) | February 23,2025 | February 25, 2024 (e) |
| Segment net sales | ||||
| North America | $986.3 | $947.5 | $3,162.1 | $3,250.0 |
| International | 534.2 | 510.8 | 1,613.4 | 1,605.7 |
| $1,520.5 | $1,458.3 | $4,775.5 | $4,855.7 | |
| Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||
|---|---|---|---|---|
| (in millions) | February 23,2025 | February 25, 2024 (g)(h) | February 23,2025 | February 25, 2024 (g)(h) |
| Segment Adjusted EBITDA | ||||
| North America (a) | $300.7 | $285.9 | $843.5 | $986.6 |
| International (a) | 93.2 | 101.7 | 191.1 | 291.5 |
| Total Reportable Segments Adjusted EBITDA | 393.9 | 387.6 | 1,034.6 | 1,278.1 |
| Unallocated corporate costs (b) | (30.1) | (44.0) | (99.0) | (144.7) |
| Depreciation and amortization (c) | 98.5 | 80.0 | 282.4 | 222.0 |
| Unrealized derivative (gains) losses | (5.9) | 27.3 | (11.8) | 1.6 |
| Foreign currency exchange losses | 7.0 | 16.4 | 17.2 | 21.8 |
| Blue chip swap transaction gains (d) | (0.6) | (7.4) | (20.5) | (14.5) |
| Items impacting comparability: | ||||
| Restructuring Plan expenses (e) | 10.3 | — | 169.4 | — |
| Shareholder activism expense (f) | 3.7 | — | 4.1 | — |
| Inventory step-up from acquisition | — | — | — | 20.7 |
| Integration and acquisition-related items, net | — | 2.4 | — | 11.2 |
| Interest expense, net | 47.3 | 35.7 | 135.8 | 95.5 |
| Income before income taxes | 203.5 | 189.2 | 359.0 | 775.1 |
| Income tax expense | 57.5 | 43.1 | 121.7 | 179.3 |
| Net income | $146.0 | $146.1 | $237.3 | $595.8 |
(a)The thirteen weeks ended February 23, 2025 include an approximately $9 million benefit ($7 million after-tax) related to the voluntary product withdrawal initiated in the fourth quarter of fiscal 2024. This includes an approximately $6 million benefit ($5 million after-tax) in net sales and an approximately $3 million benefit ($2 million after-tax) in cost of sales. The total benefit was allocated to the reporting segments as follows: approximately $3 million to North America and approximately $6 million to International. The thirty-nine weeks ended February 23, 2025 include an approximately $31 million charge ($24 million after-tax) related to the voluntary product withdrawal initiated in the fourth quarter of fiscal 2024. This includes an approximately $9 million loss ($7 million after-tax) in net sales and an approximately $22 million charge ($17 million after-tax) in cost of sales. The total charge was allocated to the reporting segments as follows: approximately $19 million to North America and approximately $12 million to International.
(b)Unallocated corporate costs include costs related to corporate support staff and support services, which include, but are not limited to, our administrative, information technology, human resources, finance, and accounting functions that are not specifically allocated to the segments. In the table, unallocated corporate costs exclude unrealized derivative gains and losses, foreign currency exchange gains and losses, blue chip swap transaction gains, and items impacting comparability. These items are added back to reconcile Segment Adjusted EBITDA to Net income.
(c)Depreciation and amortization includes interest expense, income tax expense, and depreciation and amortization from equity method investments of $2.0 million and $2.1 million for the thirteen weeks ended February 23, 2025 and February 25, 2024, respectively; and $6.1 million and $6.4 million for the thirty-nine weeks ended February 23, 2025 and February 25, 2024, respectively. Depreciation expense does not include $4.5 million for the thirteen weeks ended February 23, 2025 and $33.4 million for the thirty-nine weeks ended February 23, 2025 of accelerated depreciation related to the closure of our manufacturing facility in Connell, Washington.
(d)We enter into blue chip swap transactions to transfer U.S. dollars into Argentina primarily related to funding our capacity expansion in Argentina. The blue chip swap rate can diverge significantly from Argentina's official exchange rate.
(e)Restructuring plan expenses relate to the Restructuring Plan. See Note 4, Restructuring Plan, of these Condensed Notes to Consolidated Financial Statements for additional information
(f)Represents advisory fees related to shareholder activism matters.
(g)During the thirteen and thirty-nine weeks ended February 25, 2024, we transitioned certain central systems and functions, including order to cash, produce to deliver, source to pay, and inventory management, among others in North America, to a new enterprise resource planning system. After the transition, we experienced reduced visibility into finished goods inventories at our distribution centers, resulting in a higher-than-expected effect on customer order fulfillment rates. For both the thirteen and thirty-nine weeks ended February 25, 2024, there was an approximately $83 million negative impact to North America Segment Adjusted EBITDA, approximately $5 million to International Segment Adjusted EBITDA, and approximately $7 million to unallocated corporate costs.
(h)The thirteen weeks ended February 25, 2024 included a $25.0 million charge ($19.0 million after-tax) related to a write-off of excess raw potatoes. The total charge to the reporting segments was as follows: $22.7 million to the North America segment and $2.3 million to the International segment. The thirty-nine weeks ended February 25, 2024 included a $95.9 million charge ($72.9 million after-tax) related to a write-off of excess raw potatoes. The total charge to the reporting segments was as follows: $86.0 million to the North America segment and $9.9 million to the International segment.
- COMMITMENTS, CONTINGENCIES, GUARANTEES AND LEGAL PROCEEDINGS
We have financial commitments and obligations that arise in the ordinary course of our business. These include long-term debt, lease obligations, and purchase commitments for goods and services. There have been no material changes to the commitments, contingencies, and guarantees disclosed in Note 14, Commitments, Contingencies, Guarantees, and Legal Proceedings, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K.
Beginning in June 2024, two lawsuits were filed in the U.S. District Court for the District of Idaho against the Company and certain of our current and former executive officers alleging violations of the federal securities laws. The lawsuits were consolidated in November 2024. The amended consolidated complaint alleges the defendants made misrepresentations and omissions regarding the design and implementation of our enterprise resource planning system and the Company’s pricing practices. The complaint asserts claims on behalf of a proposed class of purchasers of the Company’s common stock between July 25, 2023 and December 19, 2024. We believe the lawsuit lacks merit and intend to vigorously defend against the allegations.
In November 2024, a class action complaint was filed in the U.S. District Court for the Northern District of Illinois against the Company, certain of our subsidiaries and a number of other producers of frozen potato products alleging violations of antitrust laws. Additional class action complaints were later filed in the same court, based on similar allegations, bringing antitrust claims on behalf of putative classes of direct purchasers, commercial and institutional indirect purchasers, and end-consumer indirect purchasers. Some complaints name a data provider and a trade association as defendants, in addition to producers of frozen potato products. The complaints allege, among other things, that beginning at least as early as January 1, 2021, the defendants conspired to raise the price of frozen potato products above competitive levels in violation of U.S. antitrust laws by coordinating prices of frozen potato products and imposing lockstep price increases, allegedly facilitated by the exchange of non-public information about prices and production. The complaints on behalf of the putative classes of indirect purchasers also assert claims under various state laws, including state antitrust laws, unfair competition laws, consumer protection statutes, and common law unjust enrichment. The relief sought in the complaints includes treble damages, injunctive relief, pre- and post-judgment interest, costs and attorneys’ fees. The complaints for each putative class have been ordered to be consolidated and amended. Class actions based on similar allegations have also been filed in Canada, in the Supreme Court of British Columbia and the Superior Court of Quebec. We believe these complaints lack merit and intend to vigorously defend against the allegations. Given the preliminary stage of the proceedings, we are currently unable to predict the outcome of this matter or estimate the range of potential loss, if any, that may result.
We are also a party to various other legal actions arising in the ordinary course of our business. These claims, legal proceedings and litigation principally arise from alleged casualty, product liability, employment, and other disputes. In determining loss contingencies, we consider the likelihood of loss as well as the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recognized when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated. While any claim, proceeding or litigation has an element of uncertainty, we believe the outcome of any of these that are pending or threatened will not have a material adverse effect on our financial condition, results of operations, or cash flows.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.